🇺🇸 Zoledronic acid 5mg in United States

24 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain — 4 reports (16.67%)
  2. Death — 3 reports (12.5%)
  3. Unevaluable Event — 3 reports (12.5%)
  4. Arthralgia — 2 reports (8.33%)
  5. Bone Pain — 2 reports (8.33%)
  6. Hospitalisation — 2 reports (8.33%)
  7. Myalgia — 2 reports (8.33%)
  8. Oedema Peripheral — 2 reports (8.33%)
  9. Off Label Use — 2 reports (8.33%)
  10. Pyrexia — 2 reports (8.33%)

Source database →

Zoledronic acid 5mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Zoledronic acid 5mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Zoledronic acid 5mg in United States?

Novartis Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.